Bharath Yada - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Bharath Yada

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Drug Discovery Today|January 27, 2024

Recent advances in multitarget-directed ligands via in silico drug discoveryKrishnaiah Maddeboina, Bharath Yada, Shikha Kumari, et al.

European Journal of Medicinal Chemistry|May 21, 2026

Design, synthesis, and biological evaluation of 2-morpholino-4H-chromen-4-one derivatives as a potent dual PI3K/BRD4 inhibitorsKrishnaiah Maddeboina, Bharath Yada, Cody C McHale, et al.

Journal of Medicinal Chemistry|November 6, 2025

Discovery of a "First-in-Class" Selective Multikinase (CDK4/6/9-AURKA/B) Inhibitor, LCI133, for NeuroblastomaKrishnaiah Maddeboina, Dhananjaya Pal, Bharath Yada, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Drug Discovery Today|January 27, 2024

Recent advances in multitarget-directed ligands via in silico drug discoveryKrishnaiah Maddeboina, Bharath Yada, Shikha Kumari, et al.

European Journal of Medicinal Chemistry|May 21, 2026

Design, synthesis, and biological evaluation of 2-morpholino-4H-chromen-4-one derivatives as a potent dual PI3K/BRD4 inhibitorsKrishnaiah Maddeboina, Bharath Yada, Cody C McHale, et al.

Journal of Medicinal Chemistry|November 6, 2025

Discovery of a "First-in-Class" Selective Multikinase (CDK4/6/9-AURKA/B) Inhibitor, LCI133, for NeuroblastomaKrishnaiah Maddeboina, Dhananjaya Pal, Bharath Yada, et al.

Pageof 1